BICTF Biocure Technology Inc.

Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. Its also includes CAR-T Cell immunotherapy, Hair growth treatment, and FMD vaccine products. The company was founded on August 24, 2007 and is headquartered in Vancouver, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.10    OTCQB
As of 01/24/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  11/28/2018
Outstanding shares:  106,621,158
Average volume:  149
Market cap:   $11,003,304
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -3.70
PS ratio:   0.00
Return on equity:   193.49%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy